The end of the hysterectomy epidemic and endometrial cancer incidence: What are the unintended consequences of declining hysterectomy rates?

Frontiers in Oncology

Volumn 6, Issue APR, 2016, Pages

  Temkin, Sarah M ^a   Minasian, Lori ^a   Noone, Anne Michelle ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Corpus uterus; Endometrial; Hysterectomy

Indexed keywords

NORGESTREL; ORAL CONTRACEPTIVE AGENT;

CANCER INCIDENCE; CANCER PROGNOSIS; DIABETES MELLITUS; ENDOMETRIUM CANCER; ETHNICITY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MORBIDITY; MORTALITY; OBESITY; OVARIECTOMY; RISK FACTOR; SHORT SURVEY; SMOKING; SURVIVAL RATE; UTERUS CANCER;

EID: 84973575256     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2016.00089     Document Type: Short Survey

References (50)

1. ACOG. Choosing the route of hysterectomy for benign disease. ACOG Committee Opinion No. 444. Obstet Gynecol (2009) 114:1156-8. doi: 10.1097/AOG.0b013e3181c33c72
2. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol (2008) 198(1):.e1-7. doi:10.1016/j.ajog.2007.05.039
3. Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SN, Lu Y-S, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 122(2 Pt 1):233-41. doi:10.1097/AOG.0b013e318299a6cf
4. Cohen SL, Vitonis AF, Einarsson JI. Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy. JSLS (2014) 18(3):e2014.00096. doi:10.4293/JSLS.2014.00096
5. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit (2008) 14(1):24-31
6. Merrill RM, Layman AB, Oderda G, Asche C. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol (2008) 18(3):253-60. doi:10.1016/j.annepidem.2007.10.011
7. ACOG. ACOG practice bulletin: alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol (2008) 112(2):387-99. doi:10.1097/AOG.0b013e318183fbab
8. Sutton C. Past, present, and future of hysterectomy. J Minim Invasive Gynecol (2010) 17(4):421-35. doi:10.1016/j.jmig.2010.03.005
9. Suh-Burgmann E, Hung Y-Y, Kinney W. Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50. Am J Obstet Gynecol (2014) 211(6):.e1-7. doi:10.1016/j.ajog.2014.07.044
10. Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, et al. Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 122(2 Pt 1):210-7. doi:10.1097/AOG.0b013e318298def5
11. ACOG. Hysterectomy. In: Gynecologists ACOG, editor. Women's Health Stats & Facts. Washington, DC: ACOG (2011). p. 19-20
12. Jamison PM, Noone A-M, Ries LAG, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev (2013) 22(2):233-41. doi:10.1158/1055-9965.EPI-12-0996
13. Jacobson GF, Shaber RE, Armstrong MA, Hung Y-Y. Hysterectomy rates for benign indications. Obstet Gynecol (2006) 107(6):1278-83. doi:10.1097/01.AOG.0000210640.86628.ff
14. Merrill RM. Impact of hysterectomy and bilateral oophorectomy on -race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol (2006) 16(12):880-7. doi:10.1016/j.annepidem.2006.06.001
15. Jacoby VL, Fujimoto VY, Giudice LC, Kuppermann M, Washington AE. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol (2010) 202(6):514-21. doi:10.1016/j.ajog.2010.02.039
16. Bickell NA, Earp JA, Garrett JM, Evans AT. Gynecologists' sex, clinical beliefs, and hysterectomy rates. Am J Public Health (1994) 84(10):1649-52. doi:10.2105/AJPH.84.10.1649
17. Geller SE, Burns LR, Brailer DJ. The impact of nonclinical factors on practice variations: the case of hysterectomies. Health Serv Res (1996) 30(6):729-50
18. Siegel RL, Devesa SS, Cokkinides V, Ma J, Jemal A. State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008. Cancer Epidemiol Biomarkers Prev (2013) 22(1):25-31. doi:10.1158/1055-9965.EPI-12-0991
19. Sherman ME, Carreon JD, Lacey JV, Devesa SS. Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst (2005) 97(22):1700-2. doi:10.1093/jnci/dji378
20. Rositch AF, Nowak RG, Gravitt PE. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer (2014) 120(13):2032-8. doi:10.1002/cncr.28548
21. Wong C, Jim M, King J, Tom-Orme L, Henderson J, Saraiya M, et al. Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999-2004. Cancer Causes Control (2011) 22(12):1681-9. doi:10.1007/s10552-011-9844-2
22. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 90(6):967-73. doi:10.1016/S0029-7844(97)00534-6
23. Bower JK, Schreiner PJ, Sternfeld B, Lewis CE. Black-White differences in hysterectomy prevalence: the CARDIA Study. Am J Public Health (2009) 99(2):300-7. doi:10.2105/AJPH.2008.133702
24. Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF Jr, et al. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues (2005) 15(4):179-86. doi:10.1016/j.whi.2005.05.002
25. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin (2016) 66(1):7-30. doi:10.3322/caac.21332
26. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B. Recent changes in endometrial cancer trends among menopausal-age US women. Cancer Epidemiol (2013) 37(4):374-7. doi:10.1016/j.canep.2013.03.008
27. Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, et al. USA Endometrial Cancer Projections to 2030: should we be concerned? Future Oncol (2014) 10(16):2561-8. doi:10.2217/fon.14.192
28. Duncan ME, Seagroatt V, Goldacre MJ. Cancer of the body of the uterus: trends in mortality and incidence in England, 1985-2008. BJOG (2012) 119(3):333-9. doi:10.1111/j.1471-0528.2011.03201.x
29. Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R. The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev (2015) 24(9):1407-15. doi:10.1158/1055-9965.EPI-15-0316
30. Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review (CSR) 1975-2012. Bethesda, MD: National Cancer Institute (2015)
31. Stang A, Hawk H, Knowlton R, Gershman ST, Kuss O. Hysterectomy-corrected incidence rates of cervical and uterine cancers in Massachusetts, 1995 to 2010. Ann Epidemiol (2014) 24(11):849-54. doi:10.1016/j.annepidem.2014.07.018
32. Redburn JC, Murphy MFG. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales. BJOG (2001) 108(4):388-95. doi:10.1111/j.1471-0528.2001.00098.x
33. Luoto R, Raitanen J, Pukkala E, Anttila A. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010. Br J Cancer (2004) 90(9):1756-9. doi:10.1038/sj.bjc.6601763
34. Stang A. Impact of hysterectomy on the age-specific incidence of cervical and uterine cancer in Germany and other countries. Eur J Public Health (2012) 23(5):879-83. doi:10.1093/eurpub/cks080
35. Stang A, Merrill R, Kuss O. Prevalence-corrected hysterectomy rates by age and indication in Germany 2005-2006. Arch Gynecol Obstet (2012) 286(5):1193-200. doi:10.1007/s00404-012-2415-2
36. Hammer A, Rositch AF, Kahlert J, Gravitt PE, Blaakaer J, Søgaard M. Global epidemiology of hysterectomy: possible impact on gynecological cancer rates. Am J Obstet Gynecol (2015) 213(1):23-9. doi:10.1016/j.ajog.2015.02.019
37. Cote M, Alhajj T, Ruterbusch J, Bernstein L, Brinton L, Blot W, et al. Risk factors for endometrial cancer in black and white women: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Cancer Causes Control (2015) 26(2):287-96. doi:10.1007/s10552-014-0510-3
38. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 19(12):3119-30. doi:10.1158/1055-9965.EPI-10-0832
39. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin (2015) 65(1):5-29. doi:10.3322/caac.21254
40. Silverberg E, Lubera J. Cancer statistics, 1987. CA Cancer J Clin (1987) 37(1):2-19. doi:10.3322/canjclin.37.1.2
41. Wright JD, Fiorelli J, SchiffPB, Burke WM, Kansler AL, Cohen CJ, et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer (2009) 115(6):1276-85. doi:10.1002/cncr.24160
42. Sorosky JI. Endometrial cancer. Obstet Gynecol (2012) 120(2 Pt 1):383-97. doi:10.1097/AOG.0b013e3182605bf1
43. Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol (2013) 130(3):652-9. doi:10.1016/j.ygyno.2013.05.020
44. Sherman ME, Devesa SS. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer (2003) 98(1):176-86. doi:10.1002/cncr.11484
45. Setiawan VW, Pike MC, Kolonel LN, Nomura AM, Goodman MT, Henderson BE. Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol (2007) 165(3):262-70. doi:10.1093/aje/kwk010
46. Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM, et al. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer (1998) 83(12):2629-37. doi:10.1002/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2
47. Oliver KE, Enewold LR, Zhu K, Conrads TP, Rose GS, Maxwell GL, et al. Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment. Gynecol Oncol (2011) 123(1):76-81. doi:10.1016/j.ygyno.2011.06.027
48. Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR. Trends in endometrial cancer incidence rates in the United States, 1999-2006. J Womens Health (2011) 20(8):1157-63. doi:10.1089/jwh.2010.2529
49. Farley J, Risinger JI, Rose GS, Maxwell GL. Racial disparities in Blacks with gynecologic cancers. Cancer (2007) 110(2):234-43. doi:10.1002/cncr.22797
50. Rauh-Hain JA, Buskwofie A, Clemmer J, Boruta DM, Schorge JO, Del Carmen MG. Racial disparities in treatment of high-grade endometrial cancer in the medicare population. Obstet Gynecol (2015) 125(4):843-51. doi:10.1097/AOG.0000000000000605